China R&D Reader

All global large pharmaceutical companies have R&D centers in China, but they are using different models in their R&D efforts.
Top R&D leaders from global pharmaceutical companies, including Pfizer, Eli Lilly, Roche, AstraZeneca and Merck, explained their R&D models and lessons learned from the past years in a roundtable discussion at the Asia Pharma R&D Leaders [...]

Is consolidation the new theme in China’s fragmented CRO sector? Over the past five to ten years, an almost bewildering array of new CROs has sprung into existence. Many of them have teamed up with others to provide a broader level of services. But last week, in a surprise announcement, PPD, Inc. (NSDQ: PPDI), a [...]